Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

AIM at Melanoma

AIM at Melanoma is globally engaged and locally invested in advancing the battle against melanoma through groundbreaking research, legislative reform, education, and patient and caregiver support.

Surviving Stage IV Melanoma With Vigilance and Hope

Thursday, February 12, 2015

Tweets by @cure_magazine

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions